Get startedLog in
    Picture of HLS Therapeutics logo

    HLS — HLS Therapeutics News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareBalancedSmall CapNeutral
    All News

    Brief: HLS Therapeutics Supports Trial To Investigate Effects Of Vascepa Against COVID-19

    Picture of HLS Therapeutics logoHLS Therapeutics
    21/05/2020 21:33
    May 21 (Reuters) - HLS Therapeutics Inc  HLS.TO :
    * HLS THERAPEUTICS SUPPORTS TRIAL TO INVESTIGATE THE EFFECTS
OF
VASCEPA® (ICOSAPENT ETHYL) AGAINST COVID-19
    * HLS THERAPEUTICS INC - IN COLLABORATION WITH AMARIN, IT IS
SUPPORTING A TRIAL TO INVESTIGATE EFFECTS OF VASCEPA

Source text for Eikon:  ID:nCNWPwgHva 
Further company coverage:  HLS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on HLS Therapeutics

    See all news